Medical Cannabis for Cluster Headaches: Breaking the Cycle

What Are Cluster Headaches?

• Cluster headaches are among the most painful conditions in medicine — often described as worse than childbirth
• They occur in cyclical patterns (clusters) lasting weeks or months, with periods of remission
• Attacks last 15 minutes to 3 hours and cause severe unilateral pain around the eye
• Associated symptoms include redness, tearing, nasal congestion, and agitation
• They affect around 1 in 1,000 people, predominantly men

Cluster headaches are sometimes called ‘suicide headaches’ due to their extreme intensity. Despite their severity, they remain underdiagnosed and undertreated. Standard acute treatments include high-flow oxygen and sumatriptan injections; preventive options include verapamil and lithium. A proportion of patients remain refractory to all standard treatments — and it is here that medical cannabis is increasingly explored.

Cannabis and Cluster Headaches: Mechanisms and Evidence

• Serotonergic and endocannabinoid systems interact in the trigeminovascular pathway — implicated in cluster headaches
• Anecdotal reports of cannabis aborting cluster attacks have been consistent in patient communities
• THC may suppress hypothalamic activity — the putative generator of cluster cycles
• CBD has anti-inflammatory and vasodilatory properties relevant to trigeminal pain
• Survey data from cluster headache forums consistently identify cannabis as among the most effective self-treatments

Formal clinical trials of cannabis specifically for cluster headaches are lacking, but the mechanistic rationale and volume of patient-reported data are substantial. Cluster headache forums such as ClusterBusters have documented thousands of cases where cannabis — and psychedelics — have provided relief. UK clinicians with cluster headache expertise are cautiously incorporating cannabis into refractory treatment plans.

Prescribing Pathways for Cluster Headache in the UK

• A diagnosis from a neurologist specialising in headache medicine strengthens the prescription case
• Evidence of failed acute and preventive treatments is required by most clinics
• Both inhaled (fast-acting) and oil-based (preventive) preparations may be relevant
• Some patients use cannabis prophylactically — taken daily during cluster periods
• Others use it acutely at the first sign of an attack to reduce severity

Accessing medical cannabis for cluster headaches in the UK requires a visit to a licensed private prescribing clinic. While the evidence base is not as robust as for other indications, the severity of the condition and lack of alternatives means that most experienced clinicians will consider cannabis for treatment-refractory patients. Bring full headache diaries and your neuro correspondence to the initial consultation.

Practical Advice for Cluster Headache Patients

• Keep a detailed headache diary — note attack times, duration, severity (1-10), and potential triggers
• Identify whether your cluster headache pattern is episodic or chronic — this affects prescribing strategy
• Cannabis should not replace oxygen therapy, which remains the most evidence-based acute treatment
• Start with a low dose and assess response during a cluster period, not during remission
• Discuss any planned cannabis use with your neurologist to avoid conflicts with existing medications

Cluster headache patients exploring medical cannabis should approach the process with clear expectations and systematic documentation. The goal is typically cycle reduction, attack severity dampening, or improved sleep during cluster periods. While cannabis is unlikely to be a complete solution, many patients report meaningful improvements that justify its inclusion in an individualised treatment plan.